Choline PET/CT for prostate cancer: Main clinical applications

European Journal of Radiology

Volumn 80, Issue 2, 2011, Pages

  Fuccio, Chiara ^a   Rubello, Domenico ^b   Castellucci, Paolo ^a   Marzola, Maria Cristina ^b   Fanti, Stefano ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Choline PET CT; Prostate cancer; Restaging, Biochemical relapse; Staging

Indexed keywords

CHOLINE; PROSTATE SPECIFIC ANTIGEN;

BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL EVALUATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; HUMAN; IMAGE ANALYSIS; LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

CHOLINE; HUMANS; KINETICS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 80053639306     PISSN: 0720048X     EISSN: 18727727     Source Type: Journal    
DOI: 10.1016/j.ejrad.2010.07.023     Document Type: Review

References (64)

1. ESMO Guidelines Task Force ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of prostate cancer Ann Oncol 16 Suppl. 1 2005 i34 i36
2. S. Fanti, C. Nanni, V. Ambrosini, M.D. Gross, D. Rubello, and M. Farsad PET in genitourinary tract cancers Q J Nucl Med Mol Imaging 51 3 2007 260 271 (Pubitemid 47189064)
3. A.B. Apolo, N. Pandit-Taskar, and M.J. Morris Novel tracers and their development for the imaging of metastatic prostate cancer J Nucl Med 49 December (12) 2008 2031 2041
4. M. Ohori, M.W. Kattan, T. Utsunomiya, K. Suyama, P.T. Scardino, and T.M. Wheeler Do impalpable (T1c) cancers visible on ultrasound differ from those not visible? J Urol 169 2003 964 968 (Pubitemid 36188135)
5. F. Cornud, K. Hamida, and T. Flam Endorectal color Doppler sonography and endorectal MR imaging features of nonpalpable prostate cancer: correlation with radical prostatectomy findings AJR Am J Roentgenol 175 2000 1161 1168
6. E.J. Halpern, F. Frauscher, S.E. Strup, L.N. Nazarian, P. O'Kane, and L.G. Gomella Prostate: high-frequency Doppler US imaging for cancer detection Radiology 225 2002 71 77
7. O. Akin, E. Sala, and C.S. Moskowitz Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging Radiology 239 2006 784 792 (Pubitemid 43830614)
8. M.R. Engelbrecht, H.J. Huisman, and R.J. Laheij Discrimination of prostate cancer from normal peripheral zone and central gland tissue by using dynamic contrast-enhanced MR imaging Radiology 229 2003 248 254 (Pubitemid 37152132)
9. D.L. Buckley, C. Roberts, G.J. Parker, J.P. Logue, and C.E. Hutchinson Prostate cancer: evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - initial experience Radiology 233 2004 709 715
10. S. Ikonen, L. Kivisaari, and T. Vehmas Optimal timing of post-biopsy MR imaging of the prostate Acta Radiol 42 2001 70 73 (Pubitemid 33630131)
11. A. Qayyum, F.V. Coakley, and Y. Lu Organ confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging AJR Am J Roentgenol 183 2004 1079 1083 (Pubitemid 44185100)
12. H. Hricak, P.L. Choyke, S.C. Eberhardt, S.A. Leibel, and P.T. Scardino Imaging prostate cancer: a multidisciplinary perspective Radiology 243 2007 28 53 (Pubitemid 46579693)
13. S. Katz, and M. Rosen MR imaging and MR spectroscopy in prostate cancer management Radiol Clin North Am 44 September (5) 2006 723 734 (Pubitemid 44498741)
14. Y. Naya, K. Okihara, R.B. Evans, and R.J. Babaian Efficacy of prostatic fossa biopsy in detecting local recurrence after radical prostatectomy Urology 66 August (2) 2005 350 355 (Pubitemid 41138096)
15. T.K. Choueiri, R. Dreicer, A. Paciorek, P.R. Carroll, and B. Konety A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy J Urol 179 March (3) 2008 906 910
16. M.E. Phelps Inaugural article: positron emission tomography provides molecular imaging of biological processes Proc Natl Acad Sci U S A 97 2000 9226 9233 (Pubitemid 30627544)
17. H. Schoder, K. Herrmann, and M. Gonen 2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy Clin Cancer Res 11 2005 4761 4769 (Pubitemid 41557196)
18. G. Sandblom, J. Sorensen, N. Lundin, M. Haggman, and P.U. Malmstrom Positron patients with prostate-specific antigen relapse after radical prostatectomy Urology 67 2006 996 1000
19. F. Dehdashti, J. Picus, and J.M. Michalski Positron tomographic assessment of androgen receptors in prostatic carcinoma Eur J Nucl Med Mol Imaging 32 2005 344 350 (Pubitemid 40562127)
20. 11C-methionine positron emission tomography J Urol 173 2005 66 69 (Pubitemid 39627673)
21. H.R. Maecke, M. Hofmann, and U. Haberkorn (68)Ga-labeled peptides in tumor imaging J Nucl Med 46 January (Suppl. 1) 2005 172S 178S
22. S.H. Zeisel Dietary choline: biochemistry, physiology and pharmacology Annu Rev Nutr 1 1981 95 121
23. E. Ackerstaff, B.R. Pflug, J.B. Nelson, and Z.M. Bhujwalla Detection of increased choline compounds with proton nuclear magnetic resonance spectroscopy subsequent to malignant transformation of human prostatic epithelial cells Cancer Res 61 2001 3599 3603 (Pubitemid 32694969)
24. 11C-choline uptake in prostate cancer: a PET study Eur J Nucl Med Mol Imaging 31 2003 317 324
25. S.A. Müller, K. Holzapfel, C. Seidl, U. Treiber, B.J. Krause, and R. Senekowitsch-Schmidtke Characterization of choline uptake in prostate cancer cells following bicatulamide and docetaxel treatment Eur J Nucl Med Mol Imaging 36 September (9) 2009 1434 1442
26. T. Hara, N. Kosaka, and H. Kishi PET imaging of prostate cancer using carbon-11-choline J Nucl Med 39 1998 990 995 (Pubitemid 28270113)
27. D.B. Husarik, R. Miralbell, and M. Dubs Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 February (2) 2008 253 263
28. U.G. Mueller-Liesse, and K. Miller Imaging modalities for primary diagnosis and staging of prostate cancer Urologe A 49 February (2) 2010 190 198
29. J.P. Sedelaar, P.L. Vijverberg, and T.M. De Reijke Transrectal ultrasound in the diagnosis of prostate cancer: state of the art and perspectives Eur Urol 40 2001 275 284 (Pubitemid 34701897)
30. M. Farsad, R. Schiavina, and P. Castellucci Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis J Nucl Med 46 2005 1642 1649 (Pubitemid 46211588)
31. 11C-choline PET/CT J Nucl Med 47 2006 1249 1254 (Pubitemid 47544875)
32. 11C-choline positron emission tomography/computerized tomography for tumor localization of primary prostate cancer in comparison with 12-core biopsy J Urol 176 2006 954 960 (Pubitemid 44142558)
33. 11C-choline PET/CT Radiology 244 2007 797 806 (Pubitemid 47292091)
34. M. Zalesky, M. Urban, Z. Smerhovský, R. Zachoval, M. Lukes, and J. Heracek Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer Int J Urol 15 January (1) 2008 68 75
35. E. Sala, O. Akin, and C.S. Moskowitz Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis Radiology 238 March (3) 2006 929 937 (Pubitemid 43289924)
36. 11C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer BJU Int 99 2007 1421 1426 (Pubitemid 47164799)
37. R.E. Link, and R.A. Morton Indications for pelvic lymphadenectomy in prostate cancer Urol Clin North Am 28 August (3) 2001 491 498 (Pubitemid 32916753)
38. A.W. Partin, L.A. Mangold, D.M. Lamm, P.C. Walsh, J.I. Epstein, and J.D. Pearson Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium Urology 58 December (6) 2001 843 848 (Pubitemid 34017254)
39. A. Briganti, F.K. Chun, and A. Salonia Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy Eur Urol 49 June (6) 2006 1019 1026
40. P.I. Karakiewicz, and G.C. Hutterer Predictive models and prostate cancer Nat Clin Pract Urol 5 February (2) 2008 82 92 (Pubitemid 351248097)
41. J.F. Danella, J.B. deKernion, R.B. Smith, and J. Steckel The contemporary incidence of lymph node metastases in prostate cancer: implications for laparoscopic lymph node dissection J Urol 149 1993 1488 1491 (Pubitemid 23164552)
42. A. Briganti, M.L. Blute, and J.H. Eastham Pelvic lymph node dissection in prostate cancer Eur Urol 55 June (6) 2009 1251 1265
43. G.J. Jager, J.O. Barentsz, G.O. Oosterhof, J.A. Witjes, and S.J. Ruijs Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional TI-weighted magnetization-prepared-rapid gradient-echo sequence AJR Am J Roentgenol 167 1996 1503 1507 (Pubitemid 26418741)
44. A. Prando Baseline staging of newly diagnosed prostate cancer: a summary of the literature Int Braz J Urol 30 2004 341 342
45. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 25 2003 2491 2499 (Pubitemid 36706536)
46. L. Wang, H. Hricak, and M.W. Kattan Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer AJR Am J Roentgenol 186 2006 743 748 (Pubitemid 46100258)
47. 11C-choline PET J Nucl Med 44 2003 331 335 (Pubitemid 39586006)
48. R. Schiavina, V. Scattoni, and P. Castellucci (11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms Eur Urol 54 2008 392 401
49. 18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients Radiology 254 March (3) 2010 925 933
50. T. Steuber, T. Schlomm, and H. Heinzer Salomon [F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: preliminary results from a prospective histology-based study Eur J Cancer 46 January (2) 2010 449 455
51. M.H. Poulsen, K. Bouchelouche, and O. Gerke [(18)F]-fluorocholine positron-emission/computed tomography for lymph node staging of patients with prostate cancer: preliminary results of a prospective study BJU Int January 2010 doi:10.1111/j.1464-410X.2009.09191.x
52. G. Martorana, R. Schiavina, and A. Franceschelli Should we perform imaging-guided lymph node dissection in patients with lymphatic recurrence of prostate cancer after radical prostatectomy? Eur Urol 55 2009 1302 1304
53. M.L. Cher, F.J. Bianco Jr, and J.S. Lam Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy J Urol 160 1998 1387 1391 (Pubitemid 29480523)
54. P. Gomez, M. Manoharan, S.S. Kim, and M.S. Soloway Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated? BJU Int 94 2004 299 302 (Pubitemid 39120167)
55. A. Sciarra, V. Panebianco, and S. Salciccia Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer Eur Urol 54 September (3) 2008 589 600
56. S.N. Reske, N.M. Blumstein, and G. Glatting [(11)C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy Eur J Nucl Med Mol Imaging 35 2008 9 17 (Pubitemid 350234137)
57. M. Picchio, C. Messa, and C. Landoni Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography J Urol 169 2003 1337 1340 (Pubitemid 36323779)
58. V. Scattoni, M. Picchio, and N. Suardi Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 2007 423 429 (Pubitemid 46963456)
59. 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer BJU Int 102 2008 446 451 (Pubitemid 352032836)
60. 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 September (9) 2009 1394 1400
61. 11C- choline PET/CT in the restaging of prostate cancer patients showing a single lesion on bone scintigraphy Ann Nucl Med 24 July (6) 2010 485 492
62. B.J. Krause, M. Souvatzoglou, and M. Tuncel The detection rate of [(11)C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 2008 18 23 (Pubitemid 350234152)
63. G. Giovacchini, M. Picchio, and E. Coradeschi Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 February (2) 2010 301 309
64. 11C choline PET/CT findings in prostate cancer patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 June (6) 2010 1106 1116